Results 101 to 110 of about 5,544 (172)

Caring for Australians and New Zealanders With Kidney Impairment Guidelines: Rapid Development of Urate Lowering Therapy Guidelines for People With CKD. [PDF]

Kidney Int Rep, 2022
Stanley IK, Phoon RKS, Toussaint ND, Cullen V, Kearns J, Dalbeth N, Johnson DW, Krishnasamy R, Tunnicliffe DJ, CARI Guidelines Steering Committee.   +9 more
europepmc   +1 more source

Improvements in Health-Related Quality of Life With Treat-to-Target Urate-Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial. [PDF]

Arthritis Care Res (Hoboken)
Barry A, England BR, Sayles H, Helget LN, Androsenko M, Wu H, Michaud K, Kramer B, Newcomb JA, Brophy MT, Davis-Karim A, Ferguson R, Pillinger MH, Neogi T, Palevsky PM, O'Dell JR, Mikuls TR.   +16 more
europepmc   +1 more source

Gout Remission With Pegloticase-Induced Intensive Urate-Lowering Therapy: A Post Hoc Clinical Trial Analysis. [PDF]

ACR Open Rheumatol
Klionsky Y, Torralba KD, Obermeyer K, Padnick-Silver L, Lam G, LaMoreaux B.   +5 more
europepmc   +1 more source

Outcomes in Patients With Multiple Myeloma and Prescribed Urate-Lowering Therapy: A Propensity-Matched Study. [PDF]

Cureus
Eidbo S, Barnett M, Lema Rodriguez D, Tsibadze N, Pappas A, Shah M, Shah A, Mayo R.   +7 more
europepmc   +1 more source

Combination of sodium-glucose cotransporter type 2 inhibitors and urate-lowering therapy in people with gout from a specialist clinic: a retrospective, single-center observational study. [PDF]

Front Med (Lausanne)
Doménech-Serrano J, García-Loiseau I, Rodríguez-Alvear C, Riesgo-Sanchis P, Moreno-Pérez Ó, Andrés M.   +5 more
europepmc   +1 more source

Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout. [PDF]

BMC Med Inform Decis Mak, 2022
Te Kampe R, Boonen A, Jansen TL, Elling JM, Flendrie M, van Eijk-Hustings Y, Janssen M, van Durme C, de Vries H.   +8 more
europepmc   +1 more source

I83. Population Use of Urate-Lowering Therapy [PDF]

Rheumatology, 2015
openaire   +1 more source

Pacific community's perceptions on how to improve uptake of urate-lowering therapy for Pacific gout patients. [PDF]

Int J Equity Health
Ofanoa S, Ofanoa M, Tu'akoi S, Lutui H, Heather M, Goodyear-Smith F.   +5 more
europepmc   +1 more source

Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout. [PDF]

Int J Med Sci, 2021
Yen FS, Wei JC, Chang CL, Yang CC, Hsu CC, Hwu CM.   +5 more
europepmc   +1 more source

The impact of urate-lowering therapy on kidney function (IMPULsKF)

Počki, 2017
The concept of trial launched in Ukraine in 2017 with POEM design and 36-months duration is presented. It aims to investigate the impact of two target levels of urate-lowering therapy caused by hyperuricemia on kidney function and chronic kidney disease (CKD) progression measured by estimated glomerular filtration rate and albuminuria in 180 patients ...
openaire   +1 more source